Skip to main content Help with accessibility Skip to main navigation

FILGOTINIB tablets (Jyseleca®▼) for treating moderately to severely active ulcerative colitis

CCG Approval Status:

Date Added: 23 - Jun - 2022
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of FILGOTINIB tablets (Jyseleca®▼), by specialists only, for treating moderately to severely active ulcerative colitis in accordance with NICE TA792.